Latest #Novo Nordisk News
CVS to restore Zepbound coverage on standard drug plans Oct. 1
CVS Health will put Zepbound back on standard CVS Caremark plans Oct. 1, alongside Fo...
Weight Loss Results Retatrutide Top 28.3% in Eli Lilly Trial
Weight loss results retatrutide showed up to 28.3% loss over 80 weeks in an Eli Lilly...
Anti-obesity Medication Retatrutide Shows Bigger Weight Loss in Lilly Trial
Anti-obesity medication retatrutide helped adults lose far more weight than existing ...
Lly Stock rises as Lilly expands into gene therapy and AI partnerships
Lly stock rises as Lilly broadens beyond GLP-1 drugs with Engage Biologics and CDD Va...
Weight Loss Pills orforglipron may help keep kilos off after GLP-1 jabs
New weight loss pills trial suggests orforglipron may help people keep weight off aft...